NBBK vs ZTS · P/E 14, rev $335.7M vs P/E 25, rev $2.47B
NB Bancorp, Inc. Common Stock (NBBK) versus Zoetis Inc (ZTS) — a side-by-side from cached financials, not a winner call.
NB Bancorp, Inc. Common Stock (NBBK) is a banks - regional company listed on US.
Zoetis Inc (ZTS) is a drug manufacturers - specialty & generic company listed on US.
Latest reported NBBK revenue for 2025-12-31 was $335.7M. Net income was $50.3M. Revenue was up 14.8% from 2024-12-31 to 2025-12-31. NBBK currently screens at market cap $863.3M and trailing P/E 14.4.
Latest reported ZTS revenue for 2026-06-30 was $2.47B. Net income was $691.0M. Revenue was up 9.1% from 2026-03-31 to 2026-06-30. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
NBBK currently screens at market cap $863.3M and trailing P/E 14.4. ZTS currently screens at market cap $64.65B and trailing P/E 24.9.
Not investment advice. Open the NBBK and ZTS stock pages for the full models.
Not investment advice.